En vivo
Endpoints NewsActing FDA commissioner pledges to prevent political interference in rare disease meetingEndpoints NewsDimension seeks up to $750M for third life sciences fund after string of successEndpoints NewsElevance talks 'practical' AIEndpoints NewsMammalian hair, roof leaks: Novo's Catalent site in Indiana under FDA scrutiny once againFierceBiotechAutobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2Lonza NewsLonza, Stipple Bio Sign ADC Licensing Deal - Contract PharmaEndpoints NewsHikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drugCellPaleogenomes reveal the evolutionary relationship between modern and cave lionsEndpoints NewsLilly, Boehringer retrench in Germany on proposed health spending cutsEndpoints NewsSupreme Court sides with Hikma in 'skinny label' caseFierceBiotechAs China biotech crackdown calls reverberate in Washington, the pushback gets louder, tooBioWorldDeaths mar ADC’s confirmatory trial with Zynlonta in DLBCL
BioWorld 27 feb 2026

MRGPRX2 antagonists disclosed in Arcus Biosciences patent

MRGPRX2 antagonists disclosed in Arcus Biosciences patent

Original
Contenido no disponible. Consulta la fuente original.